Company: PFSA
Filing Date: 2025-08-29
Form Type: S-1
Source: 0001213900-25-082672
Chunk: 285

Company: Profusa, Inc.
Filing Date: 2025-08-29
Form: S-1
Chunk 285
---
|:-------------------------|:----|:-------|------:|
| 2026                     |     |        |   145 |
| Total                    |     | $      | 1,390 |

F-44

PROFUSA, INC. AND SUBSIDIARY
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED) Note 6 — Commitments and Contingencies Operating Lease Obligations Beginning in October 2024, the Company entered into a lease agreement whereby the Company agreed to rent its office and lab facilities under month -to-monthtenancy. The monthly rent payable under the lease is $ 25thousand. This month -to-monthlease automatically renews every four months, unless written termination is provided. Operating costs for short -termleases include variable lease costs of $ 0.1million and less than $ 0.1million during the three months ended June 30, 2025 and 2024, compared to $ 0.2million and $ 0.1million during the six months ended June 30, 2025 and 2024. Starting from August 2022 the Company recognized lease expense in the amount of monthly rent as incurred. The Company recognized operating lease costs for monthly rent of $ 75thousand and $ 150thousand for each of the three and six month periods ending June 30, 2025 and 2024. Total operating lease costs with common area maintenance variable costs were $ 0.3million and $ 0.2million for the six months ended June 30, 2025 and 2024. Contingencies and Indemnifications From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of its business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and that such expenditures can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount. In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but that have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future as a result of